A critical breakthrough in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This crucial malignant inhibitor protein is frequently lost in several types of cancer, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research